Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Non-proliferative Retinopathy”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Early research (Phase 1)Study completedNCT06487845
What this trial is testing

Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Who this might be right for
Chronic Kidney DiseaseNon-proliferative Diabetic RetinopathyHealthy Volunteers
Bayer 24
Large-scale testing (Phase 3)Looking for participantsNCT06817265
What this trial is testing

Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Beletalent (Zhuhai) Pharmaceutical Co., Ltd 360
Not applicableUnknownNCT04000789
What this trial is testing

The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)

Who this might be right for
Non-Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy New Vessels on DiscDry Eye Syndromes
Dr Cipto Mangunkusumo General Hospital 96
Testing effectiveness (Phase 2)Looking for participantsNCT07259928
What this trial is testing

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

Who this might be right for
Non-Proliferative Diabetic RetinopathyRetinal Vein Occlusion
Annexin Pharmaceuticals AB 12
Large-scale testing (Phase 3)Study completedNCT00131144
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 583
Testing effectiveness (Phase 2)UnknownNCT05007262
What this trial is testing

Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

Who this might be right for
Type2 DiabetesDiabetic Retinopathy
Guizhou Bailing Group Pharmaceutical Co Ltd 240
Testing effectiveness (Phase 2)Study completedNCT04722991
What this trial is testing

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Who this might be right for
Diabetic Retinopathy
Bayer 109
Not applicableUnknownNCT01107132
What this trial is testing

Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusNon-Proliferative Diabetic RetinopathyDiabetic Macular Edema
Soroka University Medical Center 100
Not applicableNot Yet RecruitingNCT05852132
What this trial is testing

Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy

Who this might be right for
Non Proliferative Diabetic Retinopathy(NPDR)
Fei Gao 249
Testing effectiveness (Phase 2)Study completedNCT00198471
What this trial is testing

Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

Who this might be right for
Vitreous DetachmentDiabetic Retinopathy
Bausch & Lomb Incorporated 10
Large-scale testing (Phase 3)Study completedNCT00130845
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 312
Post-approval studies (Phase 4)UnknownNCT01921192
What this trial is testing

Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy

Who this might be right for
Non Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
University of Catania 160
Large-scale testing (Phase 3)UnknownNCT00908778
What this trial is testing

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Who this might be right for
Diabetic Retinopathy
Vitreoretinal Technologies, Inc. 160
Large-scale testing (Phase 3)Ended earlyNCT05066230
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Non-proliferative Diabetic Retinopathy
Kodiak Sciences Inc 253
Large-scale testing (Phase 3)Looking for participantsNCT07235085
What this trial is testing

Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc. 930
Large-scale testing (Phase 3)Ended earlyNCT00170742
What this trial is testing

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.

Who this might be right for
Proliferative Diabetic Retinopathy
Novartis 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236645
What this trial is testing

Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Not applicableUnknownNCT04103671
What this trial is testing

Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Non Proliferative Diabetic Retinopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University 272
Testing effectiveness (Phase 2)Study completedNCT02863354
What this trial is testing

Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Charles C Wykoff, PhD, MD 43
Post-approval studies (Phase 4)UnknownNCT05358080
What this trial is testing

Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non Proliferative Diabetic Retinopathy
Hanlim Pharm. Co., Ltd. 396
Next Page